ABBV Return on Tangible Equity | AbbVie Inc.

AbbVie Inc. (ABBV) Return on Tangible Equity

2026-06-30: Return Tang Equity -7.32%.
2026-03-31: Return Tang Equity -4.14%.
2025-12-31: Return Tang Equity -4.90%.
2025-09-30: Return Tang Equity -2.74%.

Complete source-backed return tang equity history.

Available history: 2014-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-7.32%
2026-03-31	-4.14%
2025-12-31	-4.90%
2025-09-30	-2.74%
2025-06-30	-4.30%
2025-03-31	-4.82%
2024-12-31	-4.95%
2024-09-30	-5.94%
2024-06-30	-6.26%
2024-03-31	-6.96%
2023-12-31	-6.30%
2023-09-30	-8.32%
2023-06-30	-10.60%
2023-03-31	-9.08%
2022-12-31	-14.54%
2022-09-30	-16.00%
2022-06-30	-14.27%
2022-03-31	-13.97%
2021-12-31	-12.51%
2021-09-30	-7.95%
2021-06-30	-6.83%
2021-03-31	-5.25%
2020-12-31	-4.57%
2020-09-30	-7.30%
2020-06-30	-6.73%
2020-03-31	-20.49%
2019-12-31	-18.58%
2019-09-30	-7.61%
2019-06-30	-9.44%
2019-03-31	-13.62%
2018-12-31	-14.07%
2018-09-30	-21.45%
2018-06-30	-17.92%
2018-03-31	-21.58%
2017-12-31	-18.79%
2017-09-30	-24.41%
2017-06-30	-23.61%
2017-03-31	-21.66%
2016-12-31	-20.05%
2016-09-30	-21.47%
2016-06-30	-19.63%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-4.90%
2024-12-31	-4.95%
2023-12-31	-6.30%
2022-12-31	-14.54%
2021-12-31	-12.51%
2020-12-31	-4.57%
2019-12-31	-18.58%
2018-12-31	-14.07%
2017-12-31	-18.79%
2016-12-31	-20.05%
2015-12-31	-24.08%
2014-12-31	-34.19%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Merck & Co., Inc. (MRK)	United States	$365.215B	99.96
JOHNSON & JOHNSON (JNJ)	United States	$652.528B	29.10
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
PFIZER INC (PFE)	United States	$162.042B	31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60